ConductScience.org, home

Paper36367262

Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.

Pereira-Souza AL and 5 others. J Refract Surg, 2022. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. Papers, record 36367262. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36367262

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience.
PubMed
Journal
J Refract Surg
PubMed
Year
2022
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
5.37
iCite
Revised in PubMed
2022-11-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pereira-Souza ALAmanda Luiza
2Ambrósio R JrRenato
3Bandeira FFrancisco
4Salomão MQMarcella Q
5Souza Lima AAcacio
6Wilson SESteven E

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Keratomileusis, Laser In SituMajor topic
Corneal DiseasesMajor topic
Corneal OpacityMajor topic
Female
Humans
Adult
Losartan
Visual Acuity
Vision Disorders
Fibrosis
Corneal Stroma
Lasers, Excimer

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT07449000Losartan for Corneal FibrosisBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
42923547Topical Losartan in the Management of Corneal Scarring from Trauma and Infection: A Case Series.Case Rep Ophthalmol2026https://conductscience.org/library/papers/42923547PubMed
42346035The Role of Epigenetics in Corneal Fibrosis.Epigenomes2026https://conductscience.org/library/papers/42346035PubMed
41778091Topical losartan to prevent stromal scarring during post-cross-linking infection in pediatric keratoconus: A case report.Am J Ophthalmol Case Rep2026https://conductscience.org/library/papers/41778091PubMed
41753041Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications.J Clin Med2026https://conductscience.org/library/papers/41753041PubMed
41594872Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies.Biology (Basel)2026https://conductscience.org/library/papers/41594872PubMed
41573013Fungal keratitis following laser assisted lenticule extraction surgery with use of losartan as an anti-scarring agent - a case report.Am J Ophthalmol Case Rep2026https://conductscience.org/library/papers/41573013PubMed
41339873Vision rehabilitation of post-Descemet membrane endothelial keratoplasty Pseudomonas keratitis utilizing losartan ophthalmic solution and scleral contact lens: a case report.J Med Case Rep2025https://conductscience.org/library/papers/41339873PubMed
41245430Topical losartan for established corneal fibrosis with machine learning-based predictors.Ther Adv Ophthalmol2025https://conductscience.org/library/papers/41245430PubMed
41146269Effect of enalapril and losartan on the expression of genes involved in inflammation, fibrogenesis, and apoptosis in orbital fibroblasts of graves' ophthalmopathy.BMC Res Notes2025https://conductscience.org/library/papers/41146269PubMed
40745008Protecting kidney function: from mechanisms to therapeutic targets and traditional Chinese medicine.Ren Fail2025https://conductscience.org/library/papers/40745008PubMed
40530230The Potential Role of Topical Losartan in Reducing Subepithelial Haze in Traumatic Laser-Assisted In Situ Keratomileusis (LASIK) Flap Avulsion.Cureus2025https://conductscience.org/library/papers/40530230PubMed
40248823Topical Losartan Treatment of Herpes Simplex Virus- or Varicella-Zoster Virus-Induced Corneal Scarring: A Case Series.Case Rep Ophthalmol2025https://conductscience.org/library/papers/40248823PubMed
40103911Effect of 0.8mg/ml Losartan on Corneal Opacities.Pak J Med Sci2025https://conductscience.org/library/papers/40103911PubMed
39665995Topical losartan ophthalmic drops - a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications.Graefes Arch Clin Exp Ophthalmol2025https://conductscience.org/library/papers/39665995PubMed
39133495Effect of Topical Losartan in the Treatment of Established Corneal Fibrosis in Rabbits.Transl Vis Sci Technol2024https://conductscience.org/library/papers/39133495PubMed
38791518Available Therapeutic Options for Corneal Neovascularization: A Review.Int J Mol Sci2024https://conductscience.org/library/papers/38791518PubMed
38540264Regenerative Therapy for Corneal Scarring Disorders.Biomedicines2024https://conductscience.org/library/papers/38540264PubMed
37934291Classic lattice corneal dystrophy: a brief review and summary of treatment modalities.Graefes Arch Clin Exp Ophthalmol2024https://conductscience.org/library/papers/37934291PubMed
37750746Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits.Transl Vis Sci Technol2023https://conductscience.org/library/papers/37750746PubMed
37603162Management of Corneal Haze After Photorefractive Keratectomy.Ophthalmol Ther2023https://conductscience.org/library/papers/37603162PubMed

See all 23 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TGFB17040PubTator's text mininghttps://conductscience.org/library/genes/7040

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36367262

GET https://conductscience.org/api/papers/v1/36367262/cited_by?page=2